PD-1 inhibition has achieved a remarkable response in various cancers, especially EBV-positive lymphoma and gastric cancer.[6,7,11] It is believed to reverse EBV-or cancer-mediated immunosuppression, thereby restoring immune function. This evidence concerns the gene PDCD1 and cancer.